BioNTech SE and Pfizer (PFE) recently received a positive recommendation from the European Medicines Agency for marketing ...

In an exclusive interview, Sally Susman, a pioneer in corporate comms, recounts finding out that Pfizer's COVID-19 vaccine ...

Demand for the jab through the NHS and privately in pharmacies has remained steady since the end of the pandemic ...

The US Centers for Disease Control and Prevention updated its recommendations for the Pfizer/BioNTech Covid-19 vaccine booster on Wednesday to include children as young as 12, at least five months ...

Turkish scientists say that Pfizer's COVID-19 vaccine can increase the risk of eye damage, causing vision loss. A new study ...

The country of origin effect is often observed in expensive or status-related products, such as wine and cars. Vaccines, on ...

The results revealed that taking both doses of Pfizer's COVID-19 vaccine led to fewer endothelial cells in the eye and ...

COVID hospitalizations rise as pediatric cases surge 03:16. Pfizer will have a COVID-19 vaccine that specifically targets the Omicron variant ready by March, the pharmaceutical company's chief ...

Eight months after authorizing the Pfizer-BioNTech COVID-19 vaccine for emergency use in the USA, the Food and Drug Administration issued its full stamp of approval.. Now that the companies ...

Kids ages 5 to 11 will soon be able to get Pfizer's low-dose COVID vaccine. CDC director Rochelle Walensky agreed with a unanimous decision of a team of advisers that the benefits outweigh the risks.

Potential COVID-19 vaccine vials from Pfizer, Oct. 31, 2020. Dado Ruvic/Reuters, FILE Early data revealed Monday that Pfizer's COVID-19 vaccine candidate could be up to 90% effective .